(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu has received conditional approval in China for treating locally advanced or metastatic HER2-positive gastric cancer, following promising results from the DESTINY-Gastric06 trial. This marks the third approval for Enhertu in China in less … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Approval, AstraZeneca, CHINA, Daiichi Sankyo, Dave Fredrickson, DESTINY-Gastric01, Dr. Lin Shen, Enhertu, HER2-Positive Gastric Cancer Treatment, partnership, safety, sustainability
(IN BRIEF) Japan’s Ministry of Health, Labor and Welfare (MHLW) has authorized the marketing and manufacturing of Dupixent® (dupilumab) for treating chronic spontaneous urticaria (CSU) in patients aged 12 years and older. This approval marks a significant milestone as Japan … Read the full press release
Posted in Business, Education, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Approval, Chronic Spontaneous Urticaria Treatment, Dupixent, Japan, safety, Sanofi
HELSINKI, 08-Nov-2018 — /EuropaWire/ — The technology group Wärtsilä’s Aquarius UV Ballast Water Management System (BWMS) has successfully completed all the required testing procedures, and has now been submitted for US Coastguard (USCG) Type Approval. This follows the International Maritime Organization’s (IMO) Type … Read the full press release
Posted in Finland, Industrial, Technology
Tagged Approval, Craig Patrick, testing, US Coastguard, USCG, Wärtsilä, Water Management System
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?